tubercidin has been researched along with Pain in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Guillot, TS; Sowa, NA; Street, SE; Taylor-Blake, B; Vihko, P; Walsh, PL; Wightman, RM; Zylka, MJ | 1 |
| Jarvis, MF; Kowaluk, EA; Lynch, JJ | 1 |
2 other study(ies) available for tubercidin and Pain
| Article | Year |
|---|---|
PAP and NT5E inhibit nociceptive neurotransmission by rapidly hydrolyzing nucleotides to adenosine.
Topics: 5'-Nucleotidase; Acid Phosphatase; Adenosine; Adenosine Monophosphate; Animals; Dipyridamole; Ganglia, Spinal; Male; Mice; Mice, Knockout; Nociception; Nucleotides; Pain; Protein Tyrosine Phosphatases; Receptor, Adenosine A1; Synaptic Transmission; Tubercidin | 2011 |
An adenosine kinase inhibitor attenuates tactile allodynia in a rat model of diabetic neuropathic pain.
Topics: Adenosine Kinase; Animals; Anti-Bacterial Agents; Blood Glucose; Body Weight; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Disease Models, Animal; Dose-Response Relationship, Drug; Enzyme Inhibitors; Male; Morphine; Narcotics; Pain; Pain Threshold; Rats; Rats, Sprague-Dawley; Streptozocin; Theophylline; Tubercidin | 1999 |